- This educational activity is offered by the College of Psychiatric and Neurologic Pharmacists in conjunction with Spire Learning with grant support from Genentech.
Activity Dates: 10/15/2012 - 10/15/2013
This course is closed. Please look for other available products in CPNP University.
If you are a psychiatric or neurologic pharmacist or healthcare professional involved in the comprehensive medication management of patients with schizophrenia, we invite you to participate in this activity.
Schizophrenia is a chronic, debilitating disorder in which successful long-term management represents a considerable clinical challenge. However, recent advances in the field are beginning to show promise toward enabling clinicians to render effective, personalized care. This activity will examine diagnostic tools for effective symptom assessment in schizophrenia and evolving theories on the pathogenesis of schizophrenia. The limitations of current antipsychotics will also be discussed, as well as the emergence of novel therapeutics with unique receptor binding profiles with the potential to improve patient outcomes.
CPNP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access CPNP course materials online, you will need:
CPNP web sites no longer fully support Microsoft Internet Explorer 9 and older or Windows Vista and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Deanna L. Kelly, PharmD, BCPP
Roger W. Sommi, PharmD, FCCP, BCPP
Steven C. Stoner, PharmD, BCPP
Elizabeth A. Winans, PharmD, BCPP
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Each module will provide 0.5 contact hours (0.05 CEUs), for a total of 2 contact hours (0.2 CEUs) of knowledge-based continuing education credit. The ACPE universal program numbers assigned to this course are: 0284-000-12-046-H01-P (0.5 contact hours), 0284-000-12-047-H01-P (0.5 contact hours), 0284-000-12-048-H01-P (0.5 contact hours), and 0284-000-12-049-H01-P (0.5 contact hours).
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of CPNP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
ACPE approved contact hours are accepted for ANCC Certification Renewal: At least 50% (37.5 hours) of your 75 continuing education hours must be formally approved continuing education hours. Formally approved continuing education hours meet one or more of the criteria listed below:
This activity is supported by an educational grant from Genentech.